Chimeric SLA-1*1502/mβ2m/PP7 complex structure reveals distinct peptide binding, optimizing mouse models for immunological research.
Background
Establishing accurate mouse models for immunological research, particularly those expressing heterologous Major Histocompatibility Complex class I (MHC-I) molecules, is crucial for understanding antigen presentation and T-cell responses. However, murine β2-microglobulin (mβ2m) can interfere with the proper folding and peptide loading of these heterologous heavy chains, potentially compromising model fidelity. This structural investigation addresses the molecular basis of this interference, aiming to refine strategies for creating more physiologically relevant models.
Study Design
Researchers investigated the structural basis of SLA-1*1502 interaction with murine β2-microglobulin (mβ2m) and a Porcine reproductive and respiratory syndrome virus (PRRSV)-derived epitope peptide (PP7). They determined the crystal structure of the chimeric complex SLA-1*1502/mβ2m/PP7. This structure was then compared to the previously reported SLA-1*1502/sβ2m/PP7 complex (with swine β2m) to identify differences in heavy-light chain interactions and peptide binding modes. The primary endpoint was the atomic-level characterization of the complex stability and peptide presentation.
Results
Murine β2-microglobulin (mβ2m) associated with SLA-1*1502 and the PP7 peptide to form a complex, albeit with lower efficiency compared to swine β2m (sβ2m). The crystal structure of the chimeric SLA-1*1502/mβ2m/PP7 complex revealed overall similar conformations to the sβ2m counterpart, but with distinct interaction patterns between the heavy and light chains, exhibiting features characteristic of both murine and porcine origins. Importantly, the peptide binding mode within the chimeric complex also showed unique local features: > The buried surface area between PP7 and the binding groove increased, and a new salt bridge formed between PP7 and residue R114 of SLA-1*1502. Structural comparisons across diverse cross-species chimeric complexes indicated that conformational shifts of bound epitope peptides are governed by the stability of the core hydrogen-bond network at the heavy-light chain interface. Substitution with human β2m triggered milder local structural distortions than murine β2m, highlighting the specific impact of mβ2m.
Key Findings
- Murine β2m associates with
SLA-1*1502and PP7 with lower efficiency than swine β2m. - Chimeric
SLA-1*1502/mβ2m/PP7complex exhibits distinct heavy-light chain interaction patterns. - The buried surface area between PP7 and the binding groove increased in the chimeric complex.
- A new salt bridge formed between PP7 and residue R114 of
SLA-1*1502. - Co-expression of
SLA-Iand swine β2m is recommended for optimized mouse models.
Why It Matters
This study provides a critical structural understanding for optimizing immunological research models. The finding that murine β2m significantly alters MHC-I complex formation and peptide binding mode means that simply expressing a heterologous MHC-I heavy chain in mice is insufficient for accurate antigen presentation. Constructing mouse models that co-express both the heterologous SLA-I and swine β2m (sβ2m) would be a more optimized strategy, ensuring more faithful representation of antigen presentation. This insight is directly relevant for researchers developing animal models for vaccine development, infectious disease, and cancer immunology, potentially leading to more predictive preclinical data and accelerating translational research.
mhc-i
beta2-microglobulin
crystallography
immunology
antigen-presentation
mouse-models